Epithelial Cell Adhesion Molecule (EpCAM) Complex Proteins Promote Transcription Factor-mediated Pluripotency Reprogramming*

Background: EpCAM is highly expressed in ESCs. However, the role of EpCAM complex proteins in pluripotency reprogramming is still unknown. Results: Overexpression of EpCAM complex proteins significantly repressed the expression of p53 and enhanced reprogramming efficiency in MEFs. Conclusion: EpCAM signaling enhance reprogramming through suppression of the p53-p21 pathway. Significance: EpCAM signaling enhance reprogramming through suppression of the p53-p21 pathway. Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein that is highly expressed in embryonic stem cells (ESCs) and its role in maintenance of pluripotency has been suggested previously. In epithelial cancer cells, activation of the EpCAM surface-to-nucleus signaling transduction pathway involves a number of membrane proteins. However, their role in somatic cell reprogramming is still unknown. Here we demonstrate that EpCAM and its associated protein, Cldn7, play a critical role in reprogramming. Quantitative RT-PCR analysis of Oct4, Sox2, Klf4, and c-Myc (OSKM) infected mouse embryonic fibroblasts (MEFs) indicated that EpCAM and Cldn7 were up-regulated during reprogramming. Analysis of numbers of alkaline phosphatase- and Nanog-positive clones, and the expression level of pluripotency-related genes demonstrated that inhibition of either EpCAM or Cldn7 expression resulted in impairment in reprogramming efficiency, whereas overexpression of EpCAM, EpCAM plus Cldn7, or EpCAM intercellular domain (EpICD) significantly enhanced reprogramming efficiency in MEFs. Furthermore, overexpression of EpCAM or EpICD significantly repressed the expression of p53 and p21 in the reprogramming MEFs, and both EpCAM and EpICD activated the promoter activity of Oct4. These observations suggest that EpCAM signaling may enhance reprogramming through up-regulation of Oct4 and possible suppression of the p53-p21 pathway. In vitro and in vivo characterization indicated that the EpCAM-reprogrammed iPSCs exhibited similar molecular and functional features to the mouse ESCs. In summary, our studies provide additional insight into the molecular mechanisms of reprogramming and suggest a more effective means of induced pluripotent stem cell generation.

[1]  Jialiang Liang,et al.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. , 2010, Cell stem cell.

[2]  Linda Jansson,et al.  CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells. , 2009, Stem cell research.

[3]  Eric S. Lander,et al.  Dissecting direct reprogramming through integrative genomic analysis , 2008, Nature.

[4]  Brigitte Mack,et al.  Nuclear signalling by tumour-associated antigen EpCAM , 2009, Nature Cell Biology.

[5]  Jürgen Weitz,et al.  A Complex of EpCAM, Claudin-7, CD44 Variant Isoforms, and Tetraspanins Promotes Colorectal Cancer Progression , 2007, Molecular Cancer Research.

[6]  Markus Münz,et al.  The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation , 2004, Oncogene.

[7]  M. Zöller,et al.  The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. , 2005, Experimental cell research.

[8]  Sheng Ding,et al.  Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. , 2008, Cell stem cell.

[9]  A. Choo,et al.  Characterization of Epithelial Cell Adhesion Molecule as a Surface Marker on Undifferentiated Human Embryonic Stem Cells , 2010, Stem cells.

[10]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[11]  A. Umezawa,et al.  Maintenance of pluripotency and self-renewal ability of mouse embryonic stem cells in the absence of tetraspanin CD9. , 2009, Differentiation; research in biological diversity.

[12]  S. Halfon,et al.  Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. , 2011, Stem cells and development.

[13]  M Vasei,et al.  Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers , 2006, British Journal of Cancer.

[14]  C W Turck,et al.  A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. , 1991, Science.

[15]  J. Emile,et al.  Profiling of the Tetraspanin Web of Human Colon Cancer Cells *S , 2006, Molecular & Cellular Proteomics.

[16]  H. Schöler,et al.  Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences , 2001, Mammalian Genome.

[17]  K. Plath,et al.  Generation of human induced pluripotent stem cells from dermal fibroblasts , 2008, Proceedings of the National Academy of Sciences.

[18]  W. Cui,et al.  Stably Transfected Human Embryonic Stem Cell Clones Express OCT4‐Specific Green Fluorescent Protein and Maintain Self‐Renewal and Pluripotency , 2005, Stem cells.

[19]  Jennifer Nichols,et al.  Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition , 2008, PLoS biology.

[20]  P. Möller,et al.  Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. , 1987, Cancer research.

[21]  X. Wang,et al.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.

[22]  O. Gires,et al.  On the abundance of EpCAM on cancer stem cells , 2009, Nature Reviews Cancer.

[23]  D. Price,et al.  Expression of Presenilin 1 and 2 (PS1 and PS2) in Human and Murine Tissues , 1996, The Journal of Neuroscience.

[24]  Hidenori Akutsu,et al.  A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. , 2009, Cell stem cell.

[25]  G. Pan,et al.  A negative feedback loop of transcription factors that controls stem cell pluripotency and self‐renewal , 2006, The FASEB Journal.

[26]  M. Zöller,et al.  Claudin-7 Regulates EpCAM-Mediated Functions in Tumor Progression , 2009, Molecular Cancer Research.

[27]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[28]  M. Herlyn,et al.  Copyright © American Society for Investigative Pathology DOI: 10.2353/ajpath.2007.060343 Tumorigenesis and Neoplastic Progression Dysregulation of Claudin-7 Leads to Loss of E-Cadherin Expression and the Increased Invasion , 2022 .

[29]  N. Copeland,et al.  Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25. , 1999, Cytokine.

[30]  I. Nagtegaal,et al.  The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. , 2003, The American journal of pathology.

[31]  H. Schöler,et al.  A combined chemical and genetic approach for the generation of induced pluripotent stem cells. , 2008, Cell stem cell.

[32]  J. Borlak,et al.  A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators , 2008, British Journal of Cancer.

[33]  H. A. Bakker,et al.  Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule , 1994, The Journal of cell biology.

[34]  Tomohiro Kono,et al.  Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells , 2010, Nature.

[35]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[36]  M. Zöller,et al.  CD44 variant isoforms associate with tetraspanins and EpCAM. , 2004, Experimental cell research.

[37]  A. Consiglio,et al.  Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1. , 2010, Genes & development.

[38]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[39]  Jiuhong Kang,et al.  E‐Cadherin‐Mediated Cell–Cell Contact Is Critical for Induced Pluripotent Stem Cell Generation , 2010, Stem cells.

[40]  T. Fleming,et al.  Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. , 2009, Cancer research.

[41]  S. Grimmond,et al.  Identification of Human Embryonic Stem Cell Surface Markers by Combined Membrane‐Polysome Translation State Array Analysis and Immunotranscriptional Profiling , 2009, Stem cells.

[42]  D. Morrish,et al.  Preparation of fibroblast-free cytotrophoblast cultures utilizing differential expression of the CD9 antigen , 1991, In Vitro Cellular & Developmental Biology - Animal.

[43]  Wenjun Guo,et al.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds , 2008, Nature Biotechnology.

[44]  H. van Goor,et al.  Expression of EpCAM is up‐regulated during regeneration of renal epithelia , 2008, The Journal of pathology.

[45]  H. Redl,et al.  Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. , 2010, Cell stem cell.

[46]  B. Mack,et al.  EpCAM Is Involved in Maintenance of the Murine Embryonic Stem Cell Phenotype , 2009, Stem cells.

[47]  M. Zöller,et al.  The tetraspanin D6.1A and its molecular partners on rat carcinoma cells. , 2005, The Biochemical journal.

[48]  T. Ichisaka,et al.  Hypoxia enhances the generation of induced pluripotent stem cells. , 2009, Cell stem cell.

[49]  Jeroen S. van Zon,et al.  Direct cell reprogramming is a stochastic process amenable to acceleration , 2009, Nature.

[50]  J. Wrana,et al.  Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. , 2010, Cell stem cell.

[51]  Hao-Wei Chang,et al.  Novel autogenic feeders derived from human embryonic stem cells (hESCs) support an undifferentiated status of hESCs in xeno-free culture conditions. , 2009, Human reproduction.

[52]  John Yu,et al.  Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells* , 2010, The Journal of Biological Chemistry.

[53]  Sung-Jan Lin,et al.  Factors from Human Embryonic Stem Cell-derived Fibroblast-like Cells Promote Topology-dependent Hepatic Differentiation in Primate Embryonic and Induced Pluripotent Stem Cells* , 2010, The Journal of Biological Chemistry.